Effectiveness and cost of radiofrequency ablation and stereotactic body radiotherapy for treatment of early-stage hepatocellular carcinoma: An analysis of SEER-medicare.

Neehar D ParikhVincent D MarshallMichael GreenTheodore S LawrenceNataliya RazumilavaDawn OwenAmit G SingalMary Feng

Published in: Journal of medical imaging and radiation oncology (2018)

In a national cohort of early stage HCC patients, treatment with RFA vs SBRT resulted in no significant difference in survival, 90-day hospitalization, or costs. These data highlight the need for a randomized clinical trial comparing these two modalities.

Keyphrases

early stage
radiofrequency ablation
end stage renal disease
radiation therapy
randomized controlled trial
chronic kidney disease
ejection fraction
newly diagnosed
systematic review
healthcare
prognostic factors
combination therapy
machine learning
lymph node
big data
artificial intelligence
affordable care act